cetirizine has been researched along with Dermatitis Medicamentosa in 30 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Excerpt | Relevance | Reference |
---|---|---|
"The paradoxical acute exacerbation of pre-existing chronic idiopathic urticaria accompanied by intense generalized pruritus, facial oedema, and dyspnoea in a 36-year-old-woman 3-4 h after a single oral dose of 10 mg cetirizine (Zyrtec tablets), suggested the presence of an underlying intolerance reaction." | 7.71 | Urticarial intolerance reaction to cetirizine. ( Damveld, B; Marsch, WC; Schröter, S, 2002) |
"We report on six cases of skin lesions induced by bortezomib in patients treated for relapsed multiple myeloma." | 3.73 | Skin lesions induced by bortezomib. ( Hajek, R; Krejci, M; Krivanova, A; Pour, L; Vorlicek, J; Zdenek, A, 2005) |
"The paradoxical acute exacerbation of pre-existing chronic idiopathic urticaria accompanied by intense generalized pruritus, facial oedema, and dyspnoea in a 36-year-old-woman 3-4 h after a single oral dose of 10 mg cetirizine (Zyrtec tablets), suggested the presence of an underlying intolerance reaction." | 3.71 | Urticarial intolerance reaction to cetirizine. ( Damveld, B; Marsch, WC; Schröter, S, 2002) |
" The objective of this study was to evaluate the impact of antihistamines upon adverse effects following ALA-PDT." | 2.84 | A randomized, double-blind, placebo-controlled clinical trial evaluating the role of systemic antihistamine therapy for the reduction of adverse effects associated with topical 5-aminolevulinic acid photodynamic therapy. ( Goldman, MP; Jones, IT; Vanaman Wilson, MJ; Wu, DC, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (13.33) | 18.2507 |
2000's | 15 (50.00) | 29.6817 |
2010's | 8 (26.67) | 24.3611 |
2020's | 3 (10.00) | 2.80 |
Authors | Studies |
---|---|
Cook, JS | 1 |
Angles, A | 1 |
Morley, E | 1 |
Diaz-Ramos, N | 2 |
Nazario, S | 2 |
Malinow-Maceo, I | 2 |
Pereira, AS | 1 |
Flor, D | 1 |
Gonçalo, M | 3 |
Vanaman Wilson, MJ | 1 |
Jones, IT | 1 |
Wu, DC | 1 |
Goldman, MP | 1 |
Belge, KI | 1 |
Fischer, J | 1 |
Glatthaar, G | 1 |
Pietschke, K | 1 |
Yazdi, AS | 1 |
Ozkol, HU | 1 |
Calka, O | 1 |
Dulger, AC | 1 |
Bulut, G | 1 |
Cohen, PR | 1 |
Kurzrock, R | 1 |
Wahl, RU | 1 |
Wurpts, G | 1 |
Merk, HF | 1 |
Kepley, JM | 1 |
Bowen, C | 1 |
Kobayashi, T | 1 |
Bhari, N | 1 |
Mahajan, R | 1 |
Singh, S | 1 |
Sharma, VK | 1 |
Mansur, AT | 1 |
Aydingöz, IE | 1 |
Andrade, P | 1 |
Brinca, A | 1 |
Inamadar, AC | 1 |
Palit, A | 1 |
Athanikar, SB | 1 |
Sampagavi, VV | 1 |
Deshmukh, NS | 1 |
Assouère, MN | 1 |
Mazereeuw-Hautier, J | 1 |
Bonafé, JL | 1 |
Lew, BL | 1 |
Haw, CR | 1 |
Lee, MH | 1 |
Kränke, B | 2 |
Mayr-Kanhäuser, S | 1 |
Mahajan, VK | 1 |
Sharma, NL | 1 |
Sharma, VC | 1 |
Namazi, MR | 1 |
Pour, L | 1 |
Hajek, R | 1 |
Zdenek, A | 1 |
Krejci, M | 1 |
Krivanova, A | 1 |
Vorlicek, J | 1 |
Cusano, F | 1 |
Ferrara, G | 1 |
Crisman, G | 1 |
Sarracco, G | 1 |
Zalaudek, I | 1 |
Argenziano, G | 1 |
Cravo, M | 1 |
Figueiredo, A | 1 |
Sharpe, GR | 1 |
Shuster, S | 1 |
Piccart, MJ | 1 |
Klijn, J | 1 |
Paridaens, R | 1 |
Nooij, M | 1 |
Mauriac, L | 1 |
Coleman, R | 1 |
Bontenbal, M | 1 |
Awada, A | 1 |
Selleslags, J | 1 |
Van Vreckem, A | 1 |
Van Glabbeke, M | 1 |
Stingeni, L | 1 |
Caraffini, S | 1 |
Agostinelli, D | 1 |
Ricci, F | 1 |
Lisi, P | 1 |
Karamfilov, T | 1 |
Wilmer, A | 1 |
Hipler, UC | 1 |
Wollina, U | 1 |
Kern, T | 1 |
Calista, D | 1 |
Schianchi, S | 1 |
Morri, M | 1 |
Nielsen, PN | 1 |
Skov, PS | 1 |
Poulsen, LK | 1 |
Schmelz, M | 1 |
Petersen, LJ | 1 |
Schmutz, JL | 1 |
Barbaud, A | 1 |
Trechot, P | 1 |
Schröter, S | 1 |
Damveld, B | 1 |
Marsch, WC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Double-blind, Placebo-controlled, Prospective Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy[NCT02451579] | 20 participants (Anticipated) | Interventional | 2015-02-28 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for cetirizine and Dermatitis Medicamentosa
Article | Year |
---|---|
Cutaneous drug eruption from cetirizine and hydroxyzine.
Topics: Adult; Cetirizine; Drug Eruptions; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; | 2004 |
3 trials available for cetirizine and Dermatitis Medicamentosa
Article | Year |
---|---|
A randomized, double-blind, placebo-controlled clinical trial evaluating the role of systemic antihistamine therapy for the reduction of adverse effects associated with topical 5-aminolevulinic acid photodynamic therapy.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Cetirizine; Double-Blind Method; Drug Eruption | 2017 |
Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Body Fluids; Breast Neoplasms; Cetirizine; Docetaxel | 1997 |
Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study.
Topics: Administration, Cutaneous; Adult; Allergens; Antitussive Agents; Cetirizine; Codeine; Cross-Over Stu | 2001 |
26 other studies available for cetirizine and Dermatitis Medicamentosa
Article | Year |
---|---|
Urticaria and edema in a 2-year-old boy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cetirizine; Child, Preschool; Diagnosi | 2021 |
Fixed drug eruption to aripiprazole, cetirizine, and hydroxyzine hydrochloride.
Topics: Aripiprazole; Cetirizine; Drug Eruptions; Histamine H1 Antagonists; Humans; Hydroxyzine | 2023 |
Fixed drug eruption to aripiprazole, cetirizine, and hydroxyzine hydrochloride.
Topics: Aripiprazole; Cetirizine; Drug Eruptions; Histamine H1 Antagonists; Humans; Hydroxyzine | 2023 |
Fixed drug eruption to aripiprazole, cetirizine, and hydroxyzine hydrochloride.
Topics: Aripiprazole; Cetirizine; Drug Eruptions; Histamine H1 Antagonists; Humans; Hydroxyzine | 2023 |
Fixed drug eruption to aripiprazole, cetirizine, and hydroxyzine hydrochloride.
Topics: Aripiprazole; Cetirizine; Drug Eruptions; Histamine H1 Antagonists; Humans; Hydroxyzine | 2023 |
A case of fixed drug eruption from cetirizine with cross-reaction to levocetirizine and hydroxyzine.
Topics: Cetirizine; Dermatitis, Allergic Contact; Drug Eruptions; Histamine H1 Antagonists; Humans; Hydroxyz | 2023 |
Diagnosis and treatment of IgE-mediated insulin hypersensitivity: two case reports.
Topics: Aged; Anti-Allergic Agents; Cetirizine; Chronic Urticaria; Diabetes Mellitus, Type 2; Drug Eruptions | 2019 |
Ursodeoxycholic acid induced generalized fixed drug eruption.
Topics: Anti-Inflammatory Agents; Cetirizine; Cholestasis; Drug Eruptions; Gallstones; Histamine H1 Antagoni | 2014 |
Anakinra-responsive lichen planus in a woman with Erdheim-Chester disease: a therapeutic enigma.
Topics: Adult; Cetirizine; Deamino Arginine Vasopressin; Diabetes Insipidus; Drug Eruptions; Erdheim-Chester | 2014 |
[Post-vaccination granulomas caused by delayed-type reaction to aluminum salts].
Topics: Adjuvants, Immunologic; Administration, Topical; Aluminum; Anti-Allergic Agents; Cetirizine; Child, | 2014 |
Rash and fever in a 14-month-old girl.
Topics: Amoxicillin; Anti-Bacterial Agents; Cetirizine; Diagnosis, Differential; Drug Eruptions; Exanthema; | 2015 |
Fixed drug eruption due to three antihistamines of a same chemical family: Cetirizine, levocetirizine, and hydroxyzine.
Topics: Cetirizine; Drug Eruptions; Histamine Antagonists; Histamine H1 Antagonists; Histamine H1 Antagonist | 2017 |
Reverse isotopic response: a rarely reported phenomenon.
Topics: Adult; Anesthetics, Local; Anti-Allergic Agents; Cetirizine; Dermatitis, Contact; Drug Eruptions; Fe | 2009 |
Patch testing in fixed drug eruptions--a 20-year review.
Topics: Acetaminophen; Adult; Aged; Allopurinol; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroi | 2011 |
Multiple fixed drug eruptions due to cetirizine.
Topics: Cetirizine; Drug Eruptions; Erythema; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle A | 2002 |
[Cutaneous drug eruption with two antihistaminic drugs of a same chemical family: cetirizine and hydroxyzine].
Topics: Aged; Anti-Allergic Agents; Cetirizine; Drug Eruptions; Histamine H1 Antagonists; Humans; Hydroxyzin | 2002 |
Urticarial reaction to the antihistamine levocetirizine dihydrochloride.
Topics: Adult; Cetirizine; Diagnosis, Differential; Drug Eruptions; Female; Histamine H1 Antagonists, Non-Se | 2005 |
Fixed drug eruption: a novel side-effect of levocetirizine.
Topics: Adult; Cetirizine; Drug Eruptions; Histamine H1 Antagonists, Non-Sedating; Humans; Lip; Male; Penis; | 2005 |
Potential clinical uses of cetirizine in dermatology.
Topics: Cetirizine; Dermatology; Drug Eruptions; Histamine H1 Antagonists; Humans; Pemphigoid, Bullous; Sarc | 2006 |
Skin lesions induced by bortezomib.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cetirizine; Combined Modality Therapy; Dexamethaso | 2005 |
Clinicopathologic features of systemic contact dermatitis from ethylenediamine in cetirizine and levocetirizine.
Topics: Allergens; Anti-Allergic Agents; Cetirizine; Dermatitis, Allergic Contact; Drug Eruptions; Ethylened | 2006 |
Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.
Topics: Cetirizine; Cross Reactions; Drug Eruptions; Female; Histamine H1 Antagonists, Non-Sedating; Humans; | 2007 |
Characterization and analysis of skin wealing by computerized non-linear regression.
Topics: Cetirizine; Computer Simulation; Drug Eruptions; Histamine; Humans; Regression Analysis; Skin; Time | 1994 |
Maculopapular and urticarial eruption from cetirizine.
Topics: Aged; Anti-Allergic Agents; Cetirizine; Diagnosis, Differential; Drug Eruptions; Female; Humans; Par | 1997 |
Cetirizine-induced urticarial reaction.
Topics: Adult; Cetirizine; Drug Eruptions; Female; Histamine H1 Antagonists; Humans; Urticaria | 1999 |
Multilocalized fixed drug eruption to the antihistamine cetirizine.
Topics: Adult; Cetirizine; Drug Eruptions; Erythema; Histamine H1 Antagonists; Humans; Male; Skin | 2000 |
Urticaria induced by cetirizine.
Topics: Adult; Cetirizine; Drug Eruptions; Female; Histamine H1 Antagonists; Humans; Urticaria | 2001 |
[The first case of lasting pigmented toxidermia induced by cetirizine (Zyrtec, Virlix) and ticlopidine].
Topics: Cetirizine; Drug Eruptions; Humans; Pigmentation Disorders; Ticlopidine | 2002 |
Urticarial intolerance reaction to cetirizine.
Topics: Acute Disease; Adult; Anti-Allergic Agents; Cetirizine; Chronic Disease; Drug Eruptions; Female; His | 2002 |